CHMP opinion on Lunivia is positive
This article was originally published in Scrip
Executive Summary
The EU's CHMPhas recommendedSepracor's Lunivia (eszopiclone) for a marketing authorisation for the treatment of insomnia in adults, including difficulty falling asleep, nocturnal awakening or early awakening, usually for short-term duration.